Oncotarget

Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study.  12:1230-1242. 2021

Prognostic and therapeutic value of the Hippo pathway, RABL6A, and p53-MDM2 axes in sarcomas.  12:740-755. 2021

Efficacy of osimertinib against EGFRvIII+ glioblastoma.  11:2074-2082. 2020

Correction: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort..  11:758. 2020

Erratum: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort (Oncotarget (2019) 10 (4857-4867) DOI: 10.18632/oncotarget.27108).  11:758. 2020

Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort.  10:4857-4867. 2019

Global gene expression of histologically normal primary skin cells from BCNS subjects reveals "single-hit" effects that are influenced by rapamycin.  10:1360-1387. 2019

Dissecting the role of RNA modification regulatory proteins in melanoma.  10:3745-3759. 2019

Editorial plasmacytomas: Many faces of one disease, or many diseases with one face?.  10:257-258. 2019

The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor.  10:5534-5548. 2019

Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability..  9:37077. 2018

Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: Evaluation of small biopsies reliability (Oncotarget (2017) 8 (90123-90131) DOI: 10.18632/oncotarget.21485).  9:37077. 2018

Integrated landscape of copy number variation and RNA expression associated with nodal metastasis in invasive ductal breast carcinoma.  9:36836-36848. 2018

Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer.  9:37662-37675. 2018

Revisiting entinostat as an immune-potentiating adjuvant.  9:37278-37279. 2018

Irradiation of pediatric glioblastoma cells promotes radioresistance and enhances glioma malignancy via genome-wide transcriptome changes..  9:34122-34131. 2018

Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? A multi-center, multi-reader investigation.  9:33804-33817. 2018

DNA Repair Molecular Beacon assay: a platform for real-time functional analysis of cellular DNA repair capacity..  9:31719-31743. 2018

PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263.  9:30465-30471. 2018

MiR-199a-3p decreases esophageal cancer cell proliferation by targeting p21 activated kinase 4.  9:28391-28407. 2018

Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model..  9:23532-23542. 2018

Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST.  9:23018-23028. 2018

Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma.  9:22665-22679. 2018

Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer [Oncotarget., 7, (2016) (86803-86815)] 10.18632/oncotarget.13466.  9:19459-19459. 2018

CKS1 expression in melanocytic nevi and melanoma.  9:4173-4187. 2018

Pre-diagnostic biomarkers of metabolic dysregulation and cancer mortality.  9:16099-16109. 2018

Zinc finger protein 598 inhibits cell survival by promoting UV-induced apoptosis.  9:5906-5918. 2018

DNA repair deregulation in discrete prostate cancer lesions identified on multi-parametric MRI and targeted by MRI/ultrasound fusion-guided biopsy..  8:68038-68046. 2017

Implementation and utilization of the molecular tumor board to guide precision medicine..  8:57845-57854. 2017

DNA repair deregulation in discrete prostate cancer lesions identified on multi-parametric MRI and targeted by MRI/ultrasound fusion-guided biopsy. 2017

BH3 mimetics suppress CXCL12 expression in human malignant peripheral nerve sheath tumor cells..  8:8670-8678. 2017

A novel small-molecule arylsulfonamide causes energetic stress and suppresses breast and lung tumor growth and metastasis.  8:99245-99260. 2017

Angiostatic actions of capsicodendrin through selective inhibition of VEGFR2-mediated AKT signaling and disregulated autophagy.  8:12675-12685. 2017

Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer.  8:91199-91208. 2017

Combination strategies enhance oncolytic virotherapy.  8:34020-34021. 2017

Dysadherin specific drug conjugates for the treatment of thyroid cancers with aggressive phenotypes.  8:24457-24468. 2017

Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth.  8:44159-44170. 2017

Exacerbation of diabetic cardiac hypertrophy in OVE26 mice by angiotensin II is associated with JNK/c-Jun/miR-221-mediated autophagy inhibition.  8:106661-106671. 2017

Functional consequence of the p53 codon 72 polymorphism in colorectal cancer.  8:76574-76586. 2017

Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemia.  8:10809-10821. 2017

Genomic regulation of invasion by STAT3 in triple negative breast cancer.  8:8226-8238. 2017

HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells.  8:27314-27327. 2017

Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth in vivo.  8:70828-70840. 2017

Hoxa9 and Hoxa10 induce CML myeloid blast crisis development through activation of Myb expression.  8:98853-98864. 2017

Identification of cellular genes and pathways important for tumorigenicity of hepatocellular carcinoma cell lines by proteomic profiling.  8:96171-96183. 2017

Implementation and utilization of the molecular tumor board to guide precision medicine.  8:57845-57854. 2017

Insufficient microwave ablation-induced promotion of distant metastasis is suppressed by β-catenin pathway inhibition in breast cancer.  8:115089-115101. 2017

Kinase analysis of penile squamous cell carcinoma on multiple platforms to identify potential therapeutic targets.  8:21710-21718. 2017

Kinomic profiling identifies focal adhesion kinase 1 as a therapeutic target in advanced clear cell renal cell carcinoma.  8:29220-29232. 2017

MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer.  8:41451-41464. 2017

Molecular characterization of pro-metastatic functions of β4- integrin in colorectal cancer.  8:92333-92345. 2017

Noncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo models.  8:9823-9834. 2017

Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity.  8:47675-47690. 2017

PD-L1 expression heterogeneity in non-small cell lung cancer: Evaluation of small biopsies reliability.  8:90123-90131. 2017

Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors.  8:76644-76655. 2017

Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling.  8:69264-69280. 2017

Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: Feasibility of an antibody-based companion diagnostic agent.  8:104303-104314. 2017

Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.  8:20198-20212. 2017

RNA sequencing-based cell proliferation analysis across 19 cancers identifies a subset of proliferation-informative cancers with a common survival signature.  8:38668-38681. 2017

RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer.  8:16387-16400. 2017

Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21^WAF1/CIP1 and p27^KIP1 pathway.  8:17216-17228. 2017

Resveratrol induces mitochondria-mediated, caspaseindependent apoptosis in murine prostate cancer cells.  8:20895-20908. 2017

Skeletal muscle measures and physical function in older adults with cancer: Sarcopenia or myopenia?.  8:33658-33665. 2017

Small G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo.  8:18031-18049. 2017

Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency.  8:65090-65099. 2017

Two new species of betatorqueviruses identified in a human melanoma that metastasized to the brain.  8:105800-105808. 2017

miR-125b regulates differentiation and metabolic reprogramming of T cell acute lymphoblastic leukemia by directly targeting A20..  7:78667-78679. 2016

Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer.  7:53984-53996. 2016

KRAS^G12 mutant induces the release of the WSTF/NRG3 complex, and contributes to an oncogenic paracrine signaling pathway.  7:53153-53164. 2016

ZKSCAN3 promotes bladder cancer cell proliferation, migration, and invasion.  7:53599-53610. 2016

Isolation, identification, and characterization of novel nanovesicles.  7:41346-41362. 2016

Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: Evidence for a biologically meaningful field effect.  7:33855-33865. 2016

Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation.  7:29901-29915. 2016

Cinobufagin inhibits tumor growth by inducing intrinsic apoptosis through AKT signaling pathway in human nonsmall cell lung cancer cells.  7:28935-28946. 2016

CLEC4C p.K210del variant causes impaired cell surface transport in plasmacytoid dendritic cells of amyotrophic lateral sclerosis..  7:24942-24949. 2016

Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma.  7:20621-20635. 2016

Novel role of STRAP in progression and metastasis of colorectal cancer through Wnt/β-catenin signaling.  7:16023-16037. 2016

Protein phosphatase, Mg²⁺/Mn²⁺-dependent 1A controls the innate antiviral and antibacterial response of macrophages during HIV-1 and Mycobacterium tuberculosis infection.  7:15394-15409. 2016

An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9.  7:14405-14414. 2016

Cilengitide in newly diagnosed glioblastoma: Biomarker expression and outcome.  7:15018-15032. 2016

Development of ⁸⁹Zr-ontuxizumab for in vivo TEM-1/endosialin PET applications.  7:13082-13092. 2016

A role for activated Cdc42 in glioblastoma multiforme invasion.  7:56958-56975. 2016

BAI1: From cancer to neurological disease.  7:17288-17289. 2016

Correction: Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: Tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients [Oncotarget, 7, 9, (2016), (10433-10447) DOI: 10.18632/oncotarget.7197].  7:60775. 2016

Crosstalk between the mitochondrial fission protein, Drp1, and the cell cycle is identified across various cancer types and can impact survival of epithelial ovarian cancer patients.  7:60021-60037. 2016

Dysregulated human Tyrosyl-DNA phosphodiesterase I acts as cellular toxin.  7:86660-86674. 2016

ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.  7:80655-80663. 2016

Fisetin, a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma.  7:1227-1241. 2016

Frequency of CD4+CD25+Foxp3+ cells in peripheral blood in relation to urinary bladder cancer malignancy indicators before and after surgical removal.  7:11450-11462. 2016

HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling.  7:11567-11579. 2016

Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells.  7:11299-11309. 2016

Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.  7:75407-75424. 2016

Inhibition of NADPH oxidase 1 activity and blocking the binding of cytosolic and membrane-bound proteins by honokiol inhibit migratory potential of melanoma cells.  7:7899-7912. 2016

Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis.  7:6088-6104. 2016

Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer.  7:17991-18005. 2016

Melanin content in melanoma metastases affects the outcome of radiotherapy.  7:17844-17853. 2016

MicroRNAs for osteosarcoma in the mouse: A meta-analysis.  7:85650-85674. 2016

Niclosamide and its analogs are potent inhibitors of Wnt/ß- catenin, mTOR and STAT3 signaling in ovarian cancer.  7:86803-86815. 2016

Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11).  7:8756-8770. 2016

Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: Tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients.  7:10433-10447. 2016

RORβ and RORη expression inversely correlates with human melanoma progression.  7:63261-63282. 2016

Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models.  7:79828-79841. 2016

SIN3A and SIN3B differentially regulate breast cancer metastasis.  7:78713-78725. 2016

Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma.  7:1598-1607. 2016

The andean anticancer herbal product BIRM causes destabilization of androgen receptor and induces caspase-8 mediated-apoptosis in prostate cancer.  7:84201-84213. 2016

The other face of miR-17-92a cluster, exhibiting tumor suppressor effects in prostate cancer.  7:73739-73753. 2016

Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo.  7:87373-87389. 2016

VPO1 mediates oxidation of LDL and formation of foam cells.  7:35500-35511. 2016

A novel SAHA-bendamustine hybrid induces apoptosis of leukemia cells.  6:20121-20131. 2015

An epigenetic auto-feedback loop regulates TGF-β type II receptor expression and function in NSCLC.  6:33237-33252. 2015

CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer.  6:8313-8322. 2015

Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.  6:25308-25319. 2015

Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells.  6:27661-27673. 2015

Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.  6:1582-1593. 2015

DNA double strand break repair defect and sensitivity to poly ADP-ribose polymerase (PARP) inhibition in human papillomavirus 16-positive head and neck squamous cell carcinoma.  6:26995-27007. 2015

Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis.  6:12080-12093. 2015

ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.  6:29860-29876. 2015

Epithelial to mesenchymal transition is associated with rapamycin resistance.  6:19500-19513. 2015

Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer.  6:12264-12278. 2015

Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells.  6:28296-28311. 2015

Genome-wide 5-hydroxymethylcytosine modification pattern is a novel epigenetic feature of globozoospermia.  6:6535-6543. 2015

Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.  6:21268-21282. 2015

Loss of the N-terminal methyltransferase NRMT1 increases sensitivity to DNA damage and promotes mammary oncogenesis.  6:12248-12263. 2015

Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma.  6:17805-17816. 2015

Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers.  6:27763-27777. 2015

Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas.  6:4330-4344. 2015

Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer.  6:16411-16421. 2015

Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.  6:17895-17910. 2015

Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: A systematic review and meta-analysis.  6:39088-39097. 2015

Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.  6:23445-23461. 2015

Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome.  6:36789-36814. 2015

Streptococcus pneumoniae induces pyroptosis through the regulation of autophagy in murine microglia.  6:44161-44178. 2015

The host cell side of latent HIV-1 infection.  6:19920-19921. 2015

Breaking Bad: how does a neuronal protein cause neuroendocrine cancer?.  5:5-6. 2014

An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine.  5:5218-5233. 2014

Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors.  5:8544-8557. 2014

Endothelial integrin α3β1 stabilizes carbohydrate-mediated tumor/endothelial cell adhesion and induces macromolecular signaling complex formation at the endothelial cell membrane.  5:1382-1389. 2014

Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine.  5:3350-3361. 2014

Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo.  5:7917-7935. 2014

GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis.  5:12151-12165. 2014

GSK-3 as potential target for therapeutic irvention in cancer.  5:2881-2911. 2014

MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1.  5:3512-3525. 2014

Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer.  5:7065-7080. 2014

SapC-DOPS-induced lysosomal cell death synergizes with TMZ in glioblastoma.  5:9703-9709. 2014

The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.  5:6654-6669. 2014

Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breas cancer cells.  5:6484-6496. 2014

Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer.  5:8750-8764. 2014

A conspiracy of glioma and endothelial cells to invade the normal brain.  2:1-4. 2011

Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers.  2:627-637. 2011

Recent advances in anti-angiogenic therapy of cancer.  2:122-134. 2011